WINTON GROUP Ltd - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 167 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,979,000
+771.8%
57,453
+322.5%
0.06%
+966.7%
Q2 2020$227,000
-67.5%
13,597
-59.2%
0.01%
-25.0%
Q3 2019$698,000
+166.4%
33,323
+305.0%
0.01%
+14.3%
Q1 2018$262,0008,2280.01%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders